Eckert & Ziegler, DE0005659700

Eckert & Ziegler stock trades at EUR 12.16 with volume 14.5 percent below average

Published on 10/08/2026 at 18:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eckert & Ziegler stock costs EUR 12.16 on October 8, 2026 after EUR 12.20, minus 0.33 percent. Market value is EUR 760.9 million.

Key points in brief

  • Eckert & Ziegler stock was at EUR 12.16 after-hours on October 8, 2026, down 0.33 percent from the prior close.
  • Trading volume of 99,109 shares was 14.5 percent below the 115,851-share average.
  • The 52-week range was EUR 11.91 to EUR 17.73, while market capitalization stood at EUR 760.9 million.
  • The next listed earnings date is November 12, 2026.
Schwarzweiß-Reportagefoto eines Nuklearmedizin-Forschers im Labor
Eckert & Ziegler DE0005659700 Nuklearmedizin: Dokumentarisches Schwarzweiß-Porträt eines Wissenschaftlers mit Isotopen-Fläschchen und Strahlenmessgerät, Illustration mit AI erstellt.

At Lang & Schwarz, Eckert & Ziegler stock was trading at EUR 12.16 after-hours on October 8, 2026 at 6:33 p.m. CEST, down 0.33 percent versus the prior close. Trading volume of 99,109 shares was 14.5 percent below the 115,851-share average on the same date.

Volume stays below average

The bid was EUR 12.02 and the ask EUR 12.29 at the same after-hours snapshot. The narrow EUR 0.27 spread puts the quoted market value between those two levels, while the share price remained above its 52-week low.

The 52-week range was EUR 11.91 to EUR 17.73 on October 8, 2026. At EUR 12.16, the stock stood 31.42 percent below its yearly high and 2.10 percent above its yearly low, making the range position more important than the small daily move.

Valuation remains measurable

Eckert & Ziegler had a market capitalization of EUR 760.9 million, a price-to-earnings ratio of 15.39 and a trailing dividend yield of 0.02 percent on October 8, 2026. The combination gives the market report a clear set of reference points without relying on the daily percentage alone.

The company operates in healthcare and medical specialties, with Medical and Isotope Products as its two operating segments, according to Eckert & Ziegler. Its investor page lists historical 2025 revenue of EUR 312.0 million and adjusted EBIT of EUR 77.7 million, figures that provide scale but do not describe the October trading session.

Comparison with peers

Eckert & Ziegler: minus 0.33 percent, P/E 15.39, market capitalization EUR 760.9 million

Sartorius (Xetra, EUR): minus 5.28 percent, P/E 87.24, market capitalization EUR 16.6 billion

Siemens Healthineers (Xetra, EUR): minus 0.78 percent, P/E 19.32, market capitalization EUR 42.8 billion

Next date is November 12

MarketScreener lists November 12, 2026 as the next earnings release date for the third quarter of 2026. That date gives the current price range a defined calendar marker, while the October 8 quotation remains an after-hours market observation.

After-hours price at EUR 12.16

The Lang & Schwarz quote was EUR 12.16 on October 8, 2026 at 6:33 p.m. CEST, with a minus 0.33 percent move for the session. The further course of trading is shown by the continuously updated real-time quote of Eckert & Ziegler stock.

Eckert & Ziegler market data

  • Company: Eckert & Ziegler SE
  • ISIN: DE0005659700
  • Ticker: EUZ.DE
  • Price Lang & Schwarz (as of October 8, 2026, 6:33 p.m. CEST): EUR 12.16
  • Change versus prior close: minus 0.33 percent
  • Prior close Lang & Schwarz (October 7, 2026): EUR 12.20
  • Market capitalization: EUR 760.9 million (as of October 8, 2026)
  • 52-week range: EUR 11.91-17.73 (as of October 8, 2026)
  • Sector / Industry: Healthcare / Medical - Specialties

Market context: Market report DAX.

More news and analyses on Eckert and Ziegler stock

Disclaimer...

en | DE0005659700 | ECKERT & ZIEGLER | boerse | 70268920 | bgmi